Premaitha Health PLC | Cash Flow

Fiscal year is April-March. All values GBP Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
4,959.00
4,933.40
7,447.50
12,116.40
7,859.00
Depreciation, Depletion & Amortization
2,203.70
243.20
258.40
557.30
737.00
Other Funds
578.50
3,328.20
2,058.10
4,872.40
1,478.80
Funds from Operations
2,176.80
1,362.10
5,131.00
6,686.70
8,600.80
Changes in Working Capital
5.10
80.60
192.90
339.90
740.80
Net Operating Cash Flow
2,171.70
1,442.70
4,938.10
7,026.70
7,860.10
Capital Expenditures
366.60
3.40
1,168.10
1,146.50
406.20
Sale of Fixed Assets & Businesses
-
-
1,229.10
0.60
400.30
Net Investing Cash Flow
366.60
3.40
61.00
1,145.90
8.50
Issuance/Reduction of Debt, Net
-
-
461.90
3,083.50
2,357.00
Net Financing Cash Flow
3,354.90
1,510.00
7,536.60
10,800.10
3,832.40
Net Change in Cash
749.40
59.20
2,659.50
2,627.50
4,036.20
Free Cash Flow
2,197.10
1,446.10
6,106.20
8,173.20
8,266.30
Net Assets from Acquisitions
-
-
-
-
2.60
Change in Capital Stock
3,354.90
1,510.00
7,074.70
7,716.60
1,475.40
Exchange Rate Effect
67.30
4.60
-
-
-

About Premaitha Health

View Profile
Address
Rutherford House
Manchester Greater Manchester M15 6SZ
United Kingdom
Employees -
Website http://premaitha.com/
Updated 09/14/2018
Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. Its product IONA test, which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom.